ATLASATLAS fair value
SEK 114.31
Close to fair value · 2% discount
Range: SEK 83–SEK 162Fair valuePrice
Vitrolife (VITR.ST)
Vitrolife stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Nasdaq Stockholm · Sweden
SEK 111.80▲ +2.66%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Vitrolife in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Vitrolife
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Vitrolife's fair value at about SEK 114.31 per share (reasonable range: SEK 83.13 to SEK 161.60). At SEK 111.80, the stock trades within 8% of that figure: close to fair value.
It is calculated with a discounted cash-flow model. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Vitrolife a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 105.61 and SEK 118.61; in 9 out of 10, between SEK 95.28 and SEK 131.48. Estimated annual volatility is 30%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 13.3B
- Market cap (USD)
- $1.3B
- 52-week high
- SEK 152.50
- 52-week low
- SEK 84.00
- Revenue (12 months)
- SEK 3.4B
- Gross margin
- 59.2%
- Operating margin
- 23.1%
- Net margin
- -147.0%
- Beta
- 1.67
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Vitrolife sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks VITR.ST has traded between SEK 84.00 and SEK 152.50. Today it is 26.7% below that high and 33% above its low.
Its beta is 1.67: it tends to move more than the market, both up and down.
About the company
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
Want to see everything about Vitrolife?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Vitrolife (VITR.ST) fair value?
About SEK 114.31 per share according to ATLAS (reasonable range: SEK 83.13 to SEK 161.60). With the stock at SEK 111.80, it is close to that value.
What is the chance VITR.ST goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, VITR.ST ends the month between SEK 105.61 and SEK 118.61.
How big is Vitrolife and what is its P/E ratio?
Vitrolife's market capitalization is SEK 13.3B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is VITR.ST?
ATLAS estimates annual volatility at 30%. In a typical month, half of the outcomes end between SEK 105.61 and SEK 118.61.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer